311770-75-9

Basic information

• Product Name: 2-methoxy-5-nitro-N-[4-(trifluoromethyl)benzyl]benzamide
• CAS NO: 311770-75-9
• Molecular Formula: C₁₆H₁₃F₃N₂O₄
• Molecular Weight: 354.2806
• Mol File: 311770-75-9.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 485.559°C at 760 mmHg
• Flash Point: 247.457°C
• Density: 1.363g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.548
• CAS DataBase Reference: 2-methoxy-5-nitro-N-[4-(trifluoromethyl)benzyl]benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-methoxy-5-nitro-N-[4-(trifluoromethyl)benzyl]benzamide(311770-75-9)
• EPA Substance Registry System: 2-methoxy-5-nitro-N-[4-(trifluoromethyl)benzyl]benzamide(311770-75-9)

Safety Data

• Hazardous Substances Data: 311770-75-9(Hazardous Substances Data)

Upstream product

• 40751-89-1 2-methoxy-5-nitrobenzoic acid 
• 3300-51-4 p-Trifluoromethylbenzylamine 
• 79-37-8 oxalyl dichloride 
• 541-41-3 chloroformic acid ethyl ester 

Downstream Products

• 311770-83-9 2-benzylsulfanyl-3-[4-methoxy-3-(4-trifluoromethyl-benzylcarbamoyl)-phenyl]-propionic acid ethyl ester 
• 311770-81-7 3-[4-methoxy-3-(4-trifluoromethyl-benzylcarbamoyl)-phenyl]-2-phenylsulfanyl-propionic acid ethyl ester 
• 311770-79-3 ethyl 2-ethylthio-3-[4-methoxy-3-[N-[[4-(trifluoromethyl)phenyl]methyl]carbamoyl]phenyl]propanoate 
• 311770-78-2 ethyl 2-bromo-3-[4-methoxy-3-[N-[[4-(trifluoromethyl)phenyl]methyl]carbamoyl]phenyl]propanoate 
• 311769-61-6 5-Amino-2-methoxy-N-[[4-(trifluoromethyl)phenyl]methyl]-benzamide 

Relevant articles and documents

Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR) α

The invention provides novel substituted phenylpropanoic acid derivatives that activate by binding to receptor as ligands of human peroxisome preliferant-activated receptor α (PPARα), and exhibit potent decreasing action on lipids in blood (cholesterol an

SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA(PPAR)

The invention provides novel substituted phenylpropanoic acid derivatives that activate by binding to receptor as ligands of human peroxisome preliferant-activated receptor α (PPARα), and exhibit potent decreasing action on lipids in blood (cholesterol and triglyceride). It relates to substituted phenylpropanoic acid derivatives represented by a general formula (1), their pharmaceutically acceptable salts and their hydrates, and processes for preparing them.